ProPhase Labs, Inc. (PRPH)
OTCMKTS · Delayed Price · Currency is USD
0.027118
-0.001982 (-6.81%)
At close: Aug 20, 2026
ProPhase Labs Market Cap
ProPhase Labs has a market cap or net worth of $380.09 thousand as of August 21, 2026. Its market cap has decreased by -97.07% in one year.
Market Cap
380.09K
Enterprise Value
9.48M
Revenue
3.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
ChartMarket Cap Chart
Since January 2, 1996, ProPhase Labs's market cap has decreased from 5.04M to 380.09K, a decrease of -92.46%. That is a compound annual growth rate of -8.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 380.09K | -81.61% |
| Dec 31, 2025 | 2.07M | -88.57% |
| Dec 31, 2024 | 18.08M | -77.84% |
| Dec 29, 2023 | 81.56M | -47.97% |
| Dec 30, 2022 | 156.75M | 41.18% |
| Dec 31, 2021 | 111.03M | 4.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Psychemedics | 15.24M |
| Aspira Women's Health | 14.79M |
| Stella Diagnostics | 2.43M |
| Hypha Labs | 2.29M |
| iMD Companies | 2.03M |
| InVitro International | 1.69M |
| IDenta | 1.18M |
| NovelStem International | 565.35K |